BOCA RATON, Fla.-- May 19, 2009 -- Pure H2O Bio-Technologies, Inc. (Pink Sheets: PRHB) announced today its receipt of a letter of intent from H.M. Northcutt Corporation, regarding the installation, monitoring and service of the first 100 Hospital Potable Water Disinfection Systems, Model 7000 as described below in Pure H20’s Pilot Program.

H.M. Northcutt Corp, located in Mt. Pleasant, South Carolina, is a company with 33 years of experience specializing in sales, installation and service of innovative water equipment. For additional information visit web-site: www.hmnorthcutt.com

Upon final National Sanitation Foundation (NSF) certification of Pure H20’s integrated Hospital Potable Water Disinfection System, Model 7000, the parties shall enter into a formal agreement detailing the objectives of Pure H20’s Pilot Program, defining the territories of installation in medical facilities within the states of Florida, Georgia and the Carolinas, monitoring and determining replacement and service costs.

In the letter of intent dated May 13, 2009, addressed to Mr. Joseph P. Doxey, President of Pure H20 Bio-Technologies, Inc., Mr. Charlie Northcutt, President of H.M. Northcutt Corp stated, “We are proud of our track record in the water treatment industry. You and your stockholders can rest assured of professional installation and service through the H.M. Northcutt Corporation.


[ Read the rest ... ]

BOCA RATON, Fla., May 04, 2009 -- Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) May 4, 2009 announced today the limitations over existing microbial removal and disinfection technologies.

There are primarily two categories of technology that address the control of microbial contaminants such as Crytosporidium oocysts in drinking water. These include (1) physical removal and (2) inactivation or disinfection of disease causing agents such as Crytosporidium parvum.

Physical Removal of Microbial Etiological Agents

Ion-exchange carbon blocks and membrane in bag filters or cartridge filters are limited to removal based on pore size and may become compromised by particulate matter including the accumulation of biological material. In addition, these systems do not appear to address the different sizes (2-6 um) of Cryptosporidium during this parasite's life-cycle which has several developmental stages: (i) motile zoite or merozoite, set free from ruptured schizonts; (ii) schizont, containing 8 merozoites when mature; (iii) mature merozoite; (iv) macrogametocyte. Filters with a 1 um nominal pore size may have a range of pore sizes from submicron to 30 um in diameter. Cryptosporidium cysts exhibit a certain cellular plasticity which enables them to pass through a 2 um pore (Crytosporidium from Molecules to Disease, pg. 298, 2003).

The common carbon-blocks systems sold for residential use typically have a functional life on the order of 2-3 months and are limited to treatment volumes of 40-100 gallons per filter.

Replacement costs of cartridge filters must be considered particularly in upscale applications. Overall, attempts at physical removal of oocysts fail to address the need to inactivate Cryptosproridium in drinking water.

Inactivation of Microbial Etiological Agents

The chlorine-resistance of Cryptosporidium is well documented in the scientific literature and is the basis for renewed interest in the control of this microbial parasite. Alternative methods of disinfection include ozone and UV-light treatment technologies.

Ozone, even when combined with chlorine post-treatment, may not inactivate all of the Cryptosoridium oocysts. Moreover, ozone dissipates quickly and its activity is limited by factors such as pH, turbidity, temperature, concentration, and carbon concentration. From a commercial or upscale perspective, ozonation is usually more expensive than chlorination and it can produce other undesirable chemical byproducts such as aldehydes, ketones, and carboxylic acids (Ozone in Water Treatment, pg. 265, 1991 and National Drinking Water Clearing house, Tech Brief, 1999).

UV-light water treatment is also limited by turbidity and may require substantial prefiltration. In addition, the intensity of the light may vary over time as the electrical elements undergo wear during repeated use. Moreover, this technology does not form a stable treatment residual and this can impact the effectiveness of the system. UV disinfection is considered to be even more expensive than ozonation.

New Technology Needed

Based on the limitations of existing water treatment technologies, there appears to be a need for more effective disinfection technology with application towards refractory water-borne parasites.

SOLUTION: Pure H20 Bio-Technologies, Inc. proprietary Silver TTO(TM) technology has the potential to disrupt the existing water treatment market in commercial, institutional as well as residential market sectors. SilverTetrasilverTetraoxide (SilverTTO(TM)) Water Disinfection of Resistant Cryptosporidium can be viewed on the Company's web-sit: www.pureh20biotech.com.

See: PRHB Hospital Potable Water Disinfection System Model 7000, Pilot Program, Informational Video, Question & Answers Special Report T.V., Participant Revenue Sharing Agreement, Description of Hospital Model 7000.

[ Read the rest ... ]

BOCA RATON, Fla., Apr 22, 2009 -- Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announces the broadcast of a live radio show on The Wall Street News Hour hosted by Michael N. Brette, J.D. Wednesday, April 22nd, at 1:00 EDT / 10:00 PDT on www.blogtalkradio.com/wallstreetnewshour.

Brette will interview Mr. Gary Schmidt of WesCom Capital, Inc. regarding Pure H20's new Pilot Program that is designed to offer an opportunity that benefits all parties involved and allows the commencement of manufacturing the first 100 Hospital Potable Water Disinfection Systems. Can now be viewed in it's entirety on the Company's web-site: www.pureh20biotech.com.

Additionally, Pure H2O's "Participant Revenue Sharing Agreement" and informational video Silver-TTO(TM) Water Disinfection of Resistant Cryptosporidium can also be viewed on the Company's website, www.pureh2Obiotech.com. E-mail us with your comments at -email-. The Wall Street News Hour broadcast interview with Mr. Schmidt will be posted on the Company's website soon.

[ Read the rest ... ]

BOCA RATON, Fla., Apr 22, 2009 -- Pure H2O Bio-Technologies, Inc. (Pink Sheets: PRHB) is proud to announce it has engaged Wescom Capital, Inc., to assist in the management, marketing and administration of Pure H20's "Pilot Program." The Company successfully completed its self underwritten financial program that offers an opportunity to selected and qualified professionals. Can now be viewed in it's entirety on the Company's web-site: www.pureh20biotech.com. The Company intends to file with the Securities and Exchange Commission Form D and related documents with the Division of Securities as deemed necessary under "Participant Revenue Sharing Agreement" ("PRSA") for its first 100 manufactured Integrated Hospital Potable Water Disinfections System known as Model 7000.

Mr. Gary Schmidt, of WesCom Capital, stated, "We are very excited about the financial opportunity regarding the "Pilot Program" offered by PRHB. We look forward to assisting them in managing and marketing the program, as well as in bringing their product to the marketplace. With pharmaceutical waste spilling into our water supply, it is obvious that there is a growing demand for absolute clean water for hospital patients, including people with weakened immune systems. It is our opinion that the company's product addresses that need and demand."

The Pilot Program is designed to offer an opportunity that benefits all parties involved. It allows the Company to seek additional capital in the form of participants sharing revenues generated from intended lease, rental or purchase agreements; it allows the Company to seek capital through government financial assistance programs for skilled workers, equipment and expansion. It allows the commencement of manufacturing the first 100 Hospital Systems; it allows expediency in regard to our micro-team, engineering team, laboratories, government agencies and officials; it allows a financial opportunity for investors to receive conservative returns and allows the Company to absorb expenses associated with NSF Certification without further dilution to shareholders.

About Pure H20 Bio-Technologies, Inc.

Pure H2O recently completed its bench, kinetic and pre-certification testing of its innovative drinking water treatment system with outstanding results. Mr. Joseph Doxey, President of Pure H2O, stated, "The engagement of Wescom Capital is a major step in the Company's move to raise capital via our Participant Revenue Sharing Agreement versus unfavorable equity sales. The Company will now join forces with Wes Com Capital, Inc., begin its marketing and sales campaign, targeting hospitals, nursing homes and medical facilities in need of pathogen-free and chemical-free water. On July 31, 2007, the Company was awarded patent #7250111, and has two additional patents pending at this time that are under review with the U.S. Patent and Trademark Office, Washington, D.C


[ Read the rest ... ]

BOCA RATON, Fla., Apr 01, 2009 -- Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announces it has received approval from Appalachian Community Bank for financing and has closed this transaction this past March 31st 2009 for its new manufacturing facility located in Blairsville, Georgia. This financing now qualifies PRHB for additional financial assistance through the Georgia Economic Development Board including equipment financing, grants, matching salaries for key employees, etc. Pure H20 has taken another step closer under NSF guidelines GP-16 Requirement and Purpose of Audit for certification of its Integrated Hospital Potable Water Disinfection System. The certification process includes completion of its manufacturing facility, located in Blairsville, GA, as well as the final certification process of its products.

Mr. Joseph P. Doxey, President said, "I believe that the community banks have gone back to fundamentals to initiate loans on behalf of small businesses. They have provided financial assistance to management of Pure H2O in the past few years to help PRHB achieve their goals that will ultimately benefit the Blairsville, GA community with the creation of jobs. It takes a community bank to set the example for the top one hundred world prime banks to take notice and follow suit. We appreciate the professional dialogue and creativity between us and the officers at Appalachian Community Bank."

Pure H2O recently completed all pre-certification testing of its innovative drinking water treatment system with outstanding results. Pure H2O is ready to complete final certification through the EPA's contractor, National Sanitation Foundation (NSF). Certification of this system is expected to be completed within this 1st quarter and has a high likelihood for success. Upon completion, the Company will begin its marketing and sales campaign. The Company intends to target hospitals, nursing homes and medical facilities in need of pathogen-free and chemical-free water.

The Company will be announcing its progress on a regular basis and will continue to keep its shareholders apprised through these final stages. Keep visiting our web-site for the latest news and updates.


[ Read the rest ... ]

BOCA RATON, Fla.--Pure H20 BIO-TECHNOLOGIES, INC. (Pink Sheets: PRHB) announced today that existing hyper-chlorine disinfection and carbon filter-based water treatment systems appear to have limits that suggest a need for improved potable water supplies in hospitals, military installations or remote locations, residences, nursing homes, day-care centers, commercial facilities, recreational facilities, cruise ships and hotels.

Many delivery systems are breaking down due to aging at the point of entry or point of use, which results in high levels of contamination with pathogenic microorganisms. Although the most common contaminants will be organisms such as E. coli, Salmonella, or Pseudomonas, there has been a significant rise in organisms that are resistant to chlorine and related halogens such as fluorine and bromine. The general way metropolitan water districts try to solve the problem is by flushing out the system and introducing high levels of free chlorine (a very toxic substance which is also corrosive to the pipes used to deliver water to the public).

Although halogens can be effective in killing pathogenic bacteria, our intended use of a tetrasilver-tetraoxide disinfectant is far superior for overall removal and/or killing of the newly emerging pathogenic strains.

Pure H2O Bio-Technologies (PRHB) predicts an enormous opportunity for its shareholder base in its plans to capitalize on the need for the world-wide growing demand for improved point-of-entry and point-of-use water treatment delivery systems. This extremely important disinfection technology developed by PRHB will provide an opportunity to address the concerns of clean drinking water not only in the United States but around the world.

Joseph P. Doxey, President of Pure H2O Bio-Technologies, Inc., stated, “The need for a robust potable water disinfection delivery system, that has the overall capacity for treating the emerging threat agents that are not killed by halogen-based/filtration systems, is now completed. We are anxiously awaiting final certification of its delivery system through EPA's contractor, National Sanitation Foundation (NSF).”

The PRHB marketing strategy is based on leveraging the Company’s water purification systems capability to disinfect rather than to simply entrap potential water-borne microbial pathogens in combination with GAC elements. This adds another level of security for prospective customers and end users. There are approximately 30,000 hospitals in the United States. This is the first target market for Pure H20, followed by other areas including, but not limited to, residential, municipal and other countries.

On July 31, 2007, the Company was awarded patent #7250111 regarding one of its delivery systems, and two additional patents are pending which are under review with the U.S. Patent and Trademark Office, Washington, D.C.

Laboratory Test Results:

Disinfection results against representative bacterial and eukaryotic parasitic agents indicate control of enteric coli form and Cryptosporidium microbial organisms. Results: Bactericidal activity ranging from greater than a 6.0 log base10 reduction of the population of Escherichia coli, a gram-negative enteric coli form bacteria (certain strains can cause fatal infections) and Pseudomonas aeruginosa, a gram-negative aerobic bacterium (certain strains can cause fatal organ abscesses). Antimicrobiocidal oocyst activity ranging up to greater than a 1.8 log base10 reduction of a Cryptosporidium oocyst population with Silver TTO™. Cryptosporidium is a pathogenic water-borne microscopic parasite. Silver TTO™ is very effective against pathogenic bacteria including Escherichia coli and Pseudomonas aeruginosa.

[ Read the rest ... ]

BOCA RATON, Fla., Jan 29, 2009 -- Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) is proud to announce it has retained the law firm of Chastain & Etcheson, LLC, located in Lewistown, Illinois, to assist in the final certification process of its Integrated Hospital Potable Water Disinfection System.
Mr. Gene Chastain, of Chastain & Etcheson, stated, "We are very excited about working with Pure H2O and in assisting them to bring their product to the marketplace. There is a growing demand for clean water and it is our opinion that the company's product addresses that demand."

Chastain & Etcheson, LLC is a law firm based out of Lewistown, Illinois. Chastain & Etcheson, LLC has a history of helping corporations with mergers and acquisitions, buyouts, obtaining financing, and all other corporate issues.
Pure H2O recently completed all pre-certification testing of its innovative drinking water treatment system with outstanding results. Pure H2O is ready to complete final certification through the EPA's contractor, National Sanitation Foundation (NSF). Certification of this system is expected to be completed within this 1st quarter and has a high likelihood for success. Upon completion, the Company will begin its marketing and sales campaign. The Company intends to target hospitals, nursing homes and medical facilities in need of pathogen-free and chemical-free water.

The certification process includes completion of its manufacturing facility, located in Blairsville, GA, as well as the final certification process of its products. Upon certification, Chastain & Etcheson will assist Pure H20 with its intended $5,000,000 mezzanine financing program. These funds will place the Company in a position to employ skilled workers in all areas of expertise.
Mr. Joseph Doxey, President of Pure H2O, stated "This engagement with Chastain & Etcheson is timely as this firm has stayed in tune with the progress of the Company. In the eyes of management they bring to us the last piece of the puzzle for Pure H20 to complete the final phase of development. We will now be able to complete our certification, manufacturing facility and bring our potable disinfection products to market. We are making a pivotal turn from years of development to revenue generation."
The Company will be announcing its progress on a regular basis and will continue to keep its shareholders apprised through these final stages. Visit our web-site for updates and to view our production Video at www.pureh20biotech.com.

On August 22, 2008 the Company successfully obtained an award of $500,000 through arbitration on its prior judgment granted in the United States Bankruptcy Court, Western District of Kentucky. On July 31, 2007, the Company was awarded patent #7250111, and has two additional patents pending at this time that are under review with the U.S. Patent and Trademark Office, Washington, D.C. The Company as of this date has approximately 640 million outstanding common shares with a float of 42 million common shares. All of the common shares issued but not in the float are restricted shares issued to non-selling insiders.

[ Read the rest ... ]

BOCA RATON, Fla.--(BUSINESS WIRE)-- Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announces the broadcast of a live radio show on The Wall Street News Hour hosted by Michael N. Brette, J.D. Wednesday, December 10, at 1:00 EST / 10:00 PST on www.blogtalkradio.com/wallstreetnewshour.

Brette will interview Pure H2O’s lead microbiologist, biochemist and toxicologist Dr. I. Cecil Felkner. He served as a principal writer, editor and project manager for the U.S. Environmental Protection Agency (EPA) and brings extensive consulting and teaching experience in the fields of microbiology, toxicology, molecular and biology/genetics. Felkner will discuss the Company’s patent-pending Silver TTO (tetrasilver tetraoxide) as the disinfectant solution to risks attributed to deadly waterborne pathogens such as Cryptosporidium and E.coli, and the urgency and necessity of its uses today.

“We are honored to be invited as a guest on the Wall Street News Hour with Mr. Michael N. Brette, J.D. and appreciate the opportunity to gain national exposure of our Silver TTO technology. We urge every listener to realize the necessity for clean potable drinking water which affects everyone in every part of the world. Our products will be ready for distribution upon completion of the certification process,” said Joseph P. Doxey, President and CEO.

Additionally, Pure H2O’s informational video Silver-TTO™ Water Disinfection of Resistant Cryptosporidium can be viewed on the Company’s website, www.pureh2Obiotech.com. E-mail us with your comments at -email-. The Wall Street News Hour broadcast interview with Dr. Felkner will be posted on the Company’s website soon.


[ Read the rest ... ]

BOCA RATON, Fla., Oct 22, 2008 -- Pure H2O Bio-Technologies, Inc. (Pink Sheets:PRHB) announced today it successfully completed Pre-Certification Testing Results for Integrated Hospital Potable Water Disinfection System.

Pure H20 Bio-Technologies, Inc. is proud to announce the successful completion of pre-certification testing of an innovative drinking water treatment system. For several months, Clancy Environmental Consultants, Inc. has been testing the efficacy of a water purification system, using tetrasilvertetraoxide (TTO) for killing pathogenic organisms not killed by the traditional water treatment by halogenated compounds such as chlorine, bromine, and fluorine. The primary goal was to achieve disinfection of Cryptosporidium parvum, a protozoan that has caused worldwide concern, including severe diarrhea in most individuals and even deaths for immunocompromised individuals, and which is especially difficult to eradicate. In addition, tests included disinfection of Escherichia coli, an important enteric pathogenic organism. Both of these pathogens enter the water distribution system due to contamination from animal and human feces.

The testing was to ensure that a complete integration of disinfectant (i.e., TTO) and the delivery system could achieve the same level of disinfection previously achieved in basic research studies performed in a batch reaction system. Briefly, successful disinfection to exceeding the level of detection of live pathogens was achieved. Chemical analyses performed in parallel with these studies assured us that the appropriate concentrations of TTO were being delivered to the holding tank, where contact with the pathogens was achieved. These results are now sufficient to allow Pure H20 Bio-Technologies, Inc., to take the system through certification, the next step before marketing, manufacturing, and sales.

These organisms are not resistant to treatment with the silverTTO which has been tested by Pure H2O Bio-Technologies, Inc. (PRHB) in laboratory level studies and is now being verified with the state-of-the-art patent-pending treatment/delivery system that is underway. The system is also designed to remove chemical contaminants and metals that are present in source water. Certification of this system through EPA's contractor, National Sanitation Foundation (NSF) is expected to be completed within a few short months and has a high likelihood for success. This system will be available to individuals and hospitals as a system delivering "pathogen-free and chemical-free" water.

Pure H2O Bio-Technologies, Inc., www.pureh20biotech.com, has been developing a water treatment system designed to kill the pathogenic microbes such as those cited above and to deliver highly purified water at the point-of-entry (POE) and point-of-use (POU), namely for residential, commercial, hospital and medical facilities. "Our potable water disinfection systems, in the near-final and certification testing stages, can provide both disinfection and purification of the contaminated water. On July 31, 2007, the Company was awarded patent #7250111, and has two additional patents pending at this time that are under review with the U.S. Patent and Trademark Office, Washington, D.C.," stated Joseph P. Doxey, President of Pure H2O Bio-Technologies, Inc.

[ Read the rest ... ]